Stivarga (regorafenib tablets - Bayer) — Cigna

Initial criteria

• Patient age ≥ 18 years
• Patient has relapsed/refractory or metastatic disease
• Patient has tried one systemic chemotherapy regimen (examples include cisplatin, doxorubicin, methotrexate, ifosfamide, cyclophosphamide, etoposide, topotecan, irinotecan, vincristine, temozolomide)
• Patient has Ewing sarcoma OR osteosarcoma

Approval duration

1 year